Marijuana Abuse Clinical Trial
Official title:
Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 2)
The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana responsible for its reinforcing effects, may decrease marijuana cravings. The purpose of this study is to evaluate the effect of THC pre-treatment on responses to marijuana-related cues versus non marijuana-related cues in individuals addicted to marijuana.
Marijuana is the most commonly used illegal drug in the United States; more than 2 million
Americans either abuse or are dependent on the drug. Therefore, there is a clear need for
treatment options. Past research on marijuana treatments has focused on alleviating
withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play
a role in treating marijuana addiction. Treatment with THC, a component of marijuana that
causes the "high" sensation, may reduce marijuana cravings. This study will evaluate the
subjective and physiological responses to marijuana-related cues versus non
marijuana-related cues in marijuana users who have been pre-treated with THC.
Participants will attend three 6-hour sessions, each separated by at least 7 days. Prior to
each testing session, participants will spend the night at the Psychiatric and Addiction
Research Center at Detroit Receiving Hospital in order to ensure no alcohol or drug use
during the 12 hours preceding the session. Participants will be randomly assigned to receive
an oral dose of 10 mg of THC, 20 mg of THC, or placebo. They will then undergo a cue
exposure test during which they will be shown a nature video and will be asked to handle and
smell various items; these will act as neutral, non marijuana-related cues. Next, the
participants will watch a video of individuals smoking marijuana and will be asked to handle
and smell marijuana-related items; these will act as the marijuana-related cues. Heart rate
and skin temperature will be monitored continuously throughout each session with the use of
electrodes and a skin thermometer. Prior to and after the cue exposure sessions blood
pressure will be measured and questionnaires will be administered to assess drug cravings as
well as related mood states. Prior to leaving the clinical center, the participants' vital
signs will be evaluated to ensure that any cue-related physiological changes have returned
to normal. Following the end of the study session, participants will have the option of
talking to a clinician experienced in dealing with drug cravings.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00158249 -
Effects of Citicoline on Brain Function and Behavior in Marijuana-Dependent Individuals
|
Phase 2 | |
Completed |
NCT00842985 -
Dronabinol Interactions in Humans
|
N/A | |
Completed |
NCT00484302 -
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
|
N/A | |
Completed |
NCT00218478 -
Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1
|
Phase 1 | |
Completed |
NCT00227864 -
A Brief Marijuana Intervention for Adolescent Women - 1
|
Phase 3 | |
Completed |
NCT00227903 -
Therapeutic Substance Abuse Treatment in Pregnancy - 1
|
Phase 2 | |
Completed |
NCT00249509 -
Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 | |
Completed |
NCT03717272 -
Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects
|
Phase 2 | |
Completed |
NCT00142961 -
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder
|
Phase 2 | |
Terminated |
NCT02102230 -
CBT-I for Cannabis Use
|
N/A | |
Completed |
NCT00580671 -
Treatment for Adolescent Marijuana Abuse
|
N/A | |
Completed |
NCT00360269 -
Atomoxetine Treatment for ADHD and Marijuana Dependence
|
Phase 2 | |
Completed |
NCT00227916 -
Motivational Interviews for Incarcerated Teens - 1
|
N/A | |
Completed |
NCT03154567 -
Effects of Stress and Drug-cue Exposure (SCM)
|
Phase 1 | |
Active, not recruiting |
NCT05322941 -
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
|
Phase 2 | |
Completed |
NCT02797990 -
Conflict Between Maternal Autonomy and Child Health in Substance-use
|
N/A | |
Completed |
NCT01762696 -
A Real-time, Contextual Intervention Using Mobile Technology to Reduce Marijuana Use in Youth
|
N/A | |
Completed |
NCT03154580 -
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
|
Phase 1 | |
Completed |
NCT00142870 -
Effectiveness of Bupropion in Treating Marijuana Dependent Individuals
|
Phase 2 |